Conclusions Single oral administration of 12-36 mg of anthocyanosides appears to lack significant effect on militarily relevant night vision tests.
Results
There were no significant differences in the mean SRT (Table 2) or DAR (Table 3) The ability to improve night vision functions of normal persons with anthocyanosides is attractive in view of the many complaints of difficulty driving or walking at night in subjects with no ocular disease. In the present study we found no effect of single-dose anthocyanosides on any of the three night vision tests previously found by us to be good predictors of actual night performance. s
Our findings contrast with those of studies carried out 20-30 years ago, l , lQ , 1l probably because of differences in study design and populations. Our double-masked, placebo-controlled, cross-over study enabled more accurate evaluation of the parameters being tested.
Moreover, anthocyanosides might have had no effect on the young subjects in our study who had excellent night vision, while they may improve the scores in individuals with low or moderate night vision ability. The discrepancy in results could also be due to differences in extracts of blueberries from different parts of the world, which might contain unequal amounts of active ingredients other than anthocyanosides.
The exact biochemical influence of anthocyanosides on the neurosensory retina is not known. It has been speculated that anthocyanosides accelerate the resynthesis of rhodopsin, ll and modulate retinal enzymatic activity 12 -mechanisms that may require longer administration to produce a measurable effect.
Further study is required to evaluate the effect of anthocyanosides on night vision: various doses of the compound should be tested for several days to weeks in subjects with moderate to low night vision ability.
